MCBI INC has a total of 38 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and computer technology are INOVA DIAGNOSTICS INC, MCBI KK and IMUSYN GMBH & CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | United States | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | China | 3 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Computer technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Electric digital data processing | |
#5 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Meno Kohji | 35 |
#2 | Uchida Kazuhiko | 34 |
#3 | Suzuki Hideaki | 33 |
#4 | Nishimura Yoshinori | 10 |
#5 | Ishii Takashi | 3 |
#6 | Matsubara Toshiya | 2 |
#7 | Ishi Takashi | 2 |
#8 | Kawakami Daisuke | 2 |
#9 | Nishiguchi Junya | 1 |
#10 | Yamaguchi Eiji | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019012671A1 | Biomarker for cognitive impairment disorders and detection method for cognitive impairment disorders using said biomarker | |
WO2019012667A1 | Biomarker for cognitive impairment disorders and detection method for cognitive impairment disorders using said biomarker | |
EP3015865A1 | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
SG10202002462UA | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
WO2007023876A1 | Method for differential analysis on amounts of substance contained in multiple samples |